A clinical overview on movement disorders

A clinical overview on movement disorders
David Shprecher, DO, MSCI, FAAN

Learning objectives:
1. Differentiate semiology, diagnostic criteria, and treatments for movement disorders.
2. Demonstrate, with video examples, the importance of semiology in clinical diagnosis.
3. Justify when to consider subspecialty referral of movement disorder patients.

Dr. Shprecher is a consultant for the following companies Neurocrine, Acadia, Amneal, Abbvie, Kyowa (relationship has ended), Supernus (relationship has ended).

Dr. Shprecher will discuss the off-label use of Fluphenazine, risperidone, topiramate, tetrabenazine - used for tics and Tourette Syndrome; Toprimate for use with essential tremor.

Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

The AOMA designates this activity for a maximum of 1.0 hours of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AOMA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOMA Grievance Policy: The Arizona Osteopathic Medical Association strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Accreditation Requirements and ACCME Accreditation Requirements. Comments, questions, or complaints should be submitted in writing to Teresa Roland, Director of Education, by mail to AOMA, 3039 W Peoria Ave, Suite C102-158, Phoenix, AZ 85029, or email teresa@azosteo.org.